SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20509
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
October 25, 2005
----------------
Date of Report
(Date of Earliest Event Reported)
Omni Medical Holdings,Inc.
--------------------------
(Exact Name of Registrant as Specified in its Charter)
Utah 000-26177 87-0425275
---- --------- ----------
(State or other juris- (Commission File No.) (IRS Employer
diction of incorporation) I.D. No.)
1257 Lake Plaza Dr., #219
Colorado Springs, CO 80906
--------------------------
(Address of Principal Executive Offices)
(719)884-2131
-------------
Telephone No.
1107 Mt. Rushmore Road
Rapid City, SD 57701
--------------------
(Former Address)
Item 7.01 Regulation FD Disclosure
See Exhibit 99, Press Release dated October 28,2005, a copy of which
is attached hereto and incorporated herein by reference. Due to this reverse
split, Omni Medical Holdings, Inc. has determined that it will abandon the
Preliminary 14C Information Statement respecting an increase in our authorized
shares that was filed with the Securities and Exchange Commission on August 8,
2005.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No. Exhibit Description
----------- -------------------
99 Press Release
* Summaries of any exhibit are modified in their entirety by this
reference to each exhibit.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized.
Omni Medical Holdings, Inc.
Date:10/25/05 /s/ Arthur Lyons
-------- ------------------------
Arthur Lyons
Chief Executive Officer